Prescribing is one of the highest-risk decisions a doctor makes. This episode breaks down the GMC’s prescribing guidance into a clear, exam-ready framework covering accountability, high-risk medicines, remote prescribing rules, consent, information-sharing, controlled drugs, off-label use and the real-world safety traps that appear repeatedly in MSRA SJT questions. You’ll also learn the exact moments where the safest option is to pause, verify or refuse a prescription entirely.
Chapters:
- Why prescribing is legally high-stakes
- Accountability: the signatory owns the risk
- Team and system influence vs individual responsibility
- Adequate knowledge and clinical justification
- Remote prescribing: when it is and isn’t safe
- Mandatory in-person rule: cosmetic injectables
- When uncertainty mandates seeing the patient
- Prescribing for yourself or relatives
- Controlled drugs and the hard prohibitions
- Emergency exceptions and documentation duties
- Preventing doctor-shopping and closing the loop
- Off-label and unlicensed medicines: added responsibilities
- Patient dialogue: risks, side effects and monitoring
- Refusal to share information with GP: when to refuse treatment
- Shared-care arrangements: clarity, suitability, best interests
- Repeat prescriptions and post-discharge safety checks
- Recognising adherence red flags
- Yellow Card Scheme requirements
- Black triangle medicines and reporting duties
- Prescribing in competitive sports: strict prohibition
- Final safety framework for the MSRA
Chapters_timestamps:
- 00:00 Accountability at the moment of signature
- 00:20 Prescribing as a legal risk assessment
- 00:58 GMC prescribing framework
- 01:22 Adequate clinical knowledge
- 01:39 Individual accountability vs team advice
- 02:00 Signatory responsibility
- 02:20 Required safety resources (BNF, NICE, MHRA)
- 02:48 Remote vs in-person prescribing
- 03:05 Mandatory physical exam for injectables
- 03:39 When uncertainty mandates face-to-face review
- 04:11 Avoid prescribing for self/relatives
- 04:26 Controlled drugs: near-total prohibition
- 05:03 Emergency exceptions
- 05:30 Preventing unsafe repeat prescribing
- 06:00 Off-label prescribing responsibilities
- 06:26 Informing patients and consent rules
- 07:01 Refusal to share with GP and safety conflict
- 07:40 Shared-care duties
- 08:20 Repeat prescription safety checks
- 09:38 Yellow Card reporting and black triangle medicines
- 10:24 Prescribing and competitive sport ethics
- 10:50 Three key takeaways
Key_takeaways:
- The doctor who signs the prescription always carries full professional accountability.
- High-risk areas (injectables, controlled drugs, off-label use) require strict safeguards and clear justification.
- When patient refusal to share information creates risk, the doctor must prioritise safety and may need to refuse treatment.
Links:
- passthemsra.com – Complete MSRA revision, notes, mocks, flashcards
- freemsra.com – Free podcasts, threads and rapid-learning guides
- msra.io – Smart MSRA Qbank with analytics
#MSRA #SJT #PrescribingSafety #GMCGuidance #GoodMedicalPractice #ControlledDrugs #OffLabelPrescribing #PatientSafety #UKDoctors #GPTraining #MedicalRevision #MedEd #passthemsra #freemsra #msraio